Jay T. Backstrom

EVP, Research and Development, Acceleron Pharma.

Companies

Agios PharmaceuticalsBoard member Jul 10, 2025 to now¹
LAVA Therapeutics NVBoard member Jan 2, 2025 to now²
Scholar Rock Holding CorpBoard member Feb 13, 2024 to Mar 12, 2025³
Scholar Rock Holding CorpChief executive officer Sep 22, 2022 to Mar 12, 2025⁴
Disc Medicine, Inc.Board member Jan 3, 2023 to Jan 3, 2023⁵
Acceleron PharmaEVP, Research and Development Dec 17, 2019 to Nov 22, 2021⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAgios Pharmaceuticals, Board member
2
SEC EDGARLAVA Therapeutics NV, Board member
3
SEC EDGARScholar Rock Holding Corp, Board member
4
SEC EDGARScholar Rock Holding Corp, Chief executive officer
5
SEC EDGARDisc Medicine, Inc., Board member
6
SEC EDGARAcceleron Pharma, EVP, Research and Development